P0158 : Influence of sustained viral response in the regression of fibrosis and portal hypertension in cirrhotic HCV genotype 1 patients treated with triple therapy

465 Black patients infected with HCV genotype 1 have a lower sustained viral response (SVR) rate to therapy with interferon + ribavirin than white patients, and this is explained by their lower neutrophil count. A prospective multicenter study of 813 U.S. Vete

Journal of Hepatology ◽

10.1016/s0168-8278(04)90465-5 ◽

2004 ◽

Vol 40 ◽

pp. 137-138

Author(s):

N. Brau ◽

E.J. Bini ◽

S. Currie ◽

H. Shen ◽

B.S. Anand ◽

...

Keyword(s):

Multicenter Study ◽

Neutrophil Count ◽

Sustained Viral Response ◽

Genotype 1 ◽

Prospective Multicenter Study ◽

Hcv Genotype ◽

Viral Response ◽

Black Patients ◽

Hcv Genotype 1 ◽

White Patients

499 VERY-EARLY VIRAL RESPONSE (WEEK-1) TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON AND RIBAVIRIN PREDICTS EXTENDED-RVR AND TREATMENT OUTCOMES IN PATIENTS WITH HCV GENOTYPE 1

Journal of Hepatology ◽

10.1016/s0168-8278(13)60501-2 ◽

2013 ◽

Vol 58 ◽

pp. S204-S205

Author(s):

K. Takaguchi ◽

H. Toyota ◽

T. Seno ◽

N. Baba ◽

T. Nagano ◽

...

Keyword(s):

Treatment Outcomes ◽

Triple Therapy ◽

Genotype 1 ◽

Hcv Genotype ◽

Viral Response ◽

Early Viral Response ◽

High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life

10.1055/s-0034-1386302 ◽

2014 ◽

Vol 52 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rate ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

End Of Treatment ◽

Hcv Genotype 1 ◽

Virologic Response Rate

Baseline predictors of an early virologic response (EVR) in previously untreated patients undergoing boceprevir (BOC) triple therapy for HCV genotype 1 infection in German real-life

10.1055/s-0034-1397212 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Early Virologic Response ◽

Hcv Genotype ◽

Baseline gamma-GT levels within the normal range predict high virologic response rates in treatment-naïve patients undergoing boceprevir triple therapy for HCV genotype 1 (G1) infection

10.1055/s-0034-1397211 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

HF Löhr ◽

G Teuber ◽

H Steffens ◽

MR Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rates ◽

Virologic Response ◽

Genotype 1 ◽

Normal Range ◽

Hcv Genotype ◽

Treatment Naïve ◽

Efficacy and safety of Boceprevir triple therapy in previously treated patients with HCV Genotype 1 (G1) infection in German real-life

10.1055/s-0035-1567991 ◽

2015 ◽

Vol 53 (12) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Efficacy And Safety ◽

Genotype 1 ◽

Hcv Genotype ◽

Previously Treated Patients ◽

Previously Treated ◽

Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy

Clinical Microbiology and Infection ◽

10.1016/j.cmi.2014.07.009 ◽

2015 ◽

Vol 21 (2) ◽

pp. 205.e1-205.e3 ◽

Cited By ~ 9

Author(s):

L. Boglione ◽

A. De Nicolò ◽

C.S. Cardellino ◽

T. Ruggiero ◽

V. Ghisetti ◽

...

Keyword(s):

Triple Therapy ◽

Plasma Concentrations ◽

Genotype 1 ◽

Hcv Genotype ◽

Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis

World Journal of Hepatology ◽

10.4254/wjh.v6.i10.759 ◽

2014 ◽

Vol 6 (10) ◽

pp. 759 ◽

Cited By ~ 3

Author(s):

Nicolae-Catalin Mechie

Keyword(s):

Protease Inhibitor ◽

Triple Therapy ◽

Meta Analysis ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv

The role of triple therapy for patients with HCV genotype 1

Hot Topics in Viral Hepatitis ◽

10.4147/htv-112207 ◽

2011 ◽

Author(s):

Mauricio Lisker-Melman

Keyword(s):

Triple Therapy ◽

Genotype 1 ◽

Hcv Genotype ◽

Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir

Liver International ◽

10.1111/liv.12424 ◽

2013 ◽

Vol 34 ◽

pp. 60-68 ◽

Cited By ~ 39

Author(s):

Tarik Asselah ◽

Patrick Marcellin

Keyword(s):

Triple Therapy ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Second Wave